United States · Series B startup

Who invested in Ambrosia Biosciences

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$100Mraised across 1 round since 2026, from 1 source

Latest round
Series B, $100MMar 2026
Investors
4
See who backed them

The rounds

  1. Mar 2026

Everyone who backed them

Janus Henderson InvestorsPrivate equity1round
Redmile GroupVC firm1round
Samsara BioCapitalVC firm1round
Blue OwlAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ambrosia Biosciences

Who invested in Ambrosia Biosciences?

Ambrosia Biosciences's investors include Janus Henderson Investors, Redmile Group, Samsara BioCapital and Blue Owl.

How much has Ambrosia Biosciences raised?

Ambrosia Biosciences has raised $100M across 1 round since 2026.

When did Ambrosia Biosciences last raise?

Ambrosia Biosciences's most recent round was a Series B of $100M in Mar 2026.

What was Ambrosia Biosciences's biggest round?

Its most recent round, $100M in Mar 2026, is also its largest on record.

Who backed Ambrosia Biosciences first?

Ambrosia Biosciences's first round on record, in Mar 2026, was backed by Janus Henderson Investors, Redmile Group and Samsara BioCapital and 1 others.

What stage is Ambrosia Biosciences at?

Ambrosia Biosciences's latest named round is a Series B, in Mar 2026.

Where is Ambrosia Biosciences based?

Ambrosia Biosciences is based in the United States.

Companies like Ambrosia Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.